Skip to main content

Study Fuels Link of IVC Filter to Venous Thromboembolism

Study Fuels Link of IVC Filter to Venous Thromboembolism

Study Fuels Link of IVC Filter to Venous Thromboembolism

Introduction

The safety and effectiveness of inferior vena cava (IVC) filters were questioned once again when a new study suggested that IVC filters might increase the risk of venous thromboembolism when used in patients with traumatic spine injuries as compared to the patients receiving chemoprophylaxis alone. Top New York City surgeons analyzed the data, the results of which were presented at the 2017 New York Surgical Society Meeting.

This data might prove to be pro-plaintiff and provide an additional support to the ongoing IVC filter lawsuits wherein nearly 4,000 lawsuits are filed mainly against C.R. Bard, Inc. and Cook Medical, Inc., claiming failure to provide appropriate safety warnings, including information regarding the importance of IVC filter retrieval. This October, bellwether trials are scheduled to begin at the U.S. District Court, Southern District of Indiana, against federally-filed lawsuits involving Cook Medical.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!